Ergebnis der Suchanfrage nach @suche@d&amp

Infineon Technologies AG

Infineon and Automotive Research Association of India collaborate to advance automotive semiconductor solutions

Helmholtz Munich

New Knowledge Portal Adiposetissue.org Enhances Obesity and Metabolism Research with Centralized Data

Marc Cain GmbH

Marc Cain Hosted an Exclusive Pop-Up Store During New York Fashion Week

nova-Institut GmbH

6

CO₂ Revolution 2025: Fueling the Future, Capturing Possibilities

Hellmann Worldwide Logistics

Hellmann: Lee I´Ons appointed new Regional CEO IMEA

UPLINK Network GmbH

Uplink Group acquires BOS-Funk operator ConnectCom in Luxembourg

DYMO Deutschland

DYMO PARTNERS WITH GA INTERNATIONAL (LABTAG) TO OFFER CRYOGENIC LABELS FOR DYMO LABELWRITER 5 SERIES PRINTERS

Hellmann Worldwide Logistics

Hellmann appoints Gilles Duffaut as new Managing Director France

Helmholtz Munich

Ancient Viral DNA Shapes Early Embryo Development

Over half of our genomes consists of thousands of remnants of ancient viral DNA, known as transposable elements, which are widespread across the tree of life. Once dismissed as the "dark side" of the genome, researchers at Helmholtz Munich and Ludwig-Maximilians-Universität (LMU) have now revealed their crucial role in early embryo development. Unanswered Questions About the Role of Ancient Viral DNA Transposable ...

Helmholtz Munich

SCP-Nano: A New Technology to Visualize Nanocarriers in Cells and Tissues

Bosch Healthcare Solutions GmbH

Vivalytic Bacterial Meningitis by Bosch: PCR rapid test for medical emergencies

Grünenthal Group

Grünenthal appoints Prof. Dr. Uli Brödl as Chief Scientific Officer

Norgine GmbH

Norgine submits Marketing Authorisation Application to the European Medicines Agency for eflornithine (difluoromethylornithine [DFMO]) in high-risk neuroblastoma

London (ots/PRNewswire) - Back to media releases Next media release Norgine today announced that it completed its marketing authorisation application filing to European Medicines Agency (EMA) for eflornithine in high-risk neuroblastoma (HRNB). This follows the submissions in April 2024, via Project Orbis, in ...

nova-Institut GmbH

6

Transforming CO₂ into Opportunities: The CO₂-Based Fuels and Chemicals Conference 2025

Accord Healthcare

Accord Healthcare is granted marketing authorisation for IMULDOSA®, ustekinumab biosimilar to Stelara®

London (ots/PRNewswire) - - Accord announces that the European Commission (EC has granted marketing authorisation for Imuldosa® (development code: DMB-3115), a biosimilar to Stelara®, indicated for a range of immune medicated inflammatory diseases. - The EC approval follows a positive opinion issued on 19 October ...

Hellmann Worldwide Logistics

Hellmann: Martin Habisreitinger appointed COO Airfreight

Helmholtz Munich

Maria-Elena Torres-Padilla Honored With the Leibniz Prize 2025

Hellmann Worldwide Logistics

3

Hellmann helps supports voluntary engagement

Helmholtz Munich

Inceptor Regulates Insulin Homeostasis: A New Approach for Diabetes Therapies

Technische Universität München

New method for designing artificial proteins

TECHNICAL UNIVERSITY OF MUNICH NEWS RELEASE Designing large new proteins with AI New method for designing artificial proteins - Efficient design of new proteins with desired properties - Size of newly designed proteins is approaching that of antibodies - Predicted protein structures successfully validated in experiments Protein design aims to create customized antibodies for therapies, biosensors for diagnostics, or ...

Hellmann Worldwide Logistics

2

Hellmann advances innovation with AI-RobotX MEA and Geekplus to enhance eCommerce fulfillment operations

nova-Institut GmbH

6

Capture, Convert, and Conquer: Innovations Wanted for the “Best CO₂ Utilisation 2025” Innovation Award

Lamilux Heinrich Strunz GmbH

LAMILUX AntiBac Wins “Best Food Safety Innovation of the Decade” at the Gulfood Manufacturing Awards 2024

Lamilux Heinrich Strunz GmbH

5

LAMILUX renovation solutions: Customised, cost-effective and energy-efficient!